4.05 USD
+0.06 (+1.5%)
4.0008 USD
-0.05 (-1.21%)
ChartMill assigns a Buy % Consensus number of 85% to GANX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.94. This target is 71.26% above the current price.
GANX was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about GANX.
In the previous month the buy percentage consensus was at a similar level.
GANX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-15 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-07 | Maxim Group | Maintains | Buy -> Buy |
| 2025-09-08 | BTIG | Reiterate | Buy -> Buy |
| 2025-08-13 | Roth Capital | Maintains | Buy -> Buy |
| 2025-07-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2024-12-24 | Roth MKM | Maintains | Buy -> Buy |
| 2024-12-05 | Roth MKM | Initiate | Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-23 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-27 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-12-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | Maxim Group | Initiate | Buy |
| 2023-08-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
GAIN THERAPEUTICS INC / GANX FAQ
What do analysts expect the price target to be for GAIN THERAPEUTICS INC (GANX)?
11 analysts have analysed GANX and the average price target is 6.94 USD. This implies a price increase of 71.26% is expected in the next year compared to the current price of 4.05.
Can you provide the consensus rating for GAIN THERAPEUTICS INC stock?
The consensus rating for GAIN THERAPEUTICS INC (GANX) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for GANX stock?
The number of analysts covering GAIN THERAPEUTICS INC (GANX) is 11.